IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Additional Paid In Capital Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Additional Paid In Capital
kr690.2m
CAGR 3-Years
0%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Additional Paid In Capital
kr3.3B
CAGR 3-Years
22%
CAGR 5-Years
24%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Additional Paid In Capital
kr6.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Additional Paid In Capital
kr921.3m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Additional Paid In Capital
kr5.5B
CAGR 3-Years
85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Additional Paid In Capital?
Additional Paid In Capital
690.2m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Additional Paid In Capital amounts to 690.2m SEK.

What is IRLAB Therapeutics AB's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
14%

Over the last year, the Additional Paid In Capital growth was 0%.

Back to Top